Thuml News

This site has affiliate links.

Try This
Cluster: lir

Stories below may also appear in other clusters. Data expires after 7 days.

All Recent News
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
californiatelegraph.com Feb 5, 2026 8:45 p.m.
Read Source
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
hawaiitelegraph.com Feb 5, 2026 6:30 p.m.
Read Source
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
tennesseedaily.com Feb 5, 2026 6:30 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
tennesseedaily.com Jan 29, 2026 8:15 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
hawaiitelegraph.com Jan 29, 2026 8:00 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
californiatelegraph.com Jan 29, 2026 7:45 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
newjerseytelegraph.com Jan 29, 2026 7:30 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Nove
pharmiweb.com Jan 29, 2026 7:30 p.m.
Read Source
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
torontotelegraph.com Jan 29, 2026 5:30 p.m.
Read Source
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
californiatelegraph.com Jan 15, 2026 7:30 p.m.
Read Source
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
newjerseytelegraph.com Jan 15, 2026 5:45 p.m.
Read Source
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
tennesseedaily.com Jan 15, 2026 5:30 p.m.
Read Source
Lir Life Sciences Corp .: LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
finanznachrichten.de Jan 15, 2026 5:30 p.m.
Read Source
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
torontotelegraph.com Jan 8, 2026 9:15 p.m.
Read Source
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
newjerseytelegraph.com Jan 8, 2026 8:15 p.m.
Read Source
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
californiatelegraph.com Jan 8, 2026 8:00 p.m.
Read Source
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
tennesseedaily.com Jan 8, 2026 8:00 p.m.
Read Source
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating ...
pr-inside.com Jan 8, 2026 6:00 p.m.
Read Source
Lir Life Sciences Corp .: LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
finanznachrichten.de Jan 8, 2026 5:30 p.m.
Read Source